Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK)

Launched by INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION SALVADOR ZUBIRAN · Apr 3, 2024

Keywords

ClinConnect Summary

The EPAK trial is studying how an educational program can help patients with chronic kidney disease (CKD) improve their eating habits and overall well-being. This program aims to teach patients about nutrition and encourage them to stick to a healthier diet, which is important for managing their condition. The trial will involve patients who are in different stages of kidney treatment, including those who are not yet on dialysis and those undergoing peritoneal or hemodialysis.

To participate, individuals must be at least 18 years old, live in Mexico City, and have been diagnosed with CKD for more than three months. Participants will attend educational sessions at the hospital twice a month for five months, where they will learn about nutrition and receive support from healthcare professionals. The study will track their dietary habits, nutritional knowledge, and quality of life before and after the program to see how effective the education is. Overall, the trial aims to help patients lead healthier lives by providing them with the tools and knowledge they need to manage their diet effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women over 18 years old
• • Residence in Mexico City, (in order to make it easier for them to attend the educational workshops that will be held within the hospital facilities).
• • Patients who are active in the nephrology office of National Institute of Medical Science and Nutrition
• • With more than 3 months of diagnosis of chronic kidney disease in pre-dialysis phase (glomerular filtration rate \< 60 ml/min/1.73m2) at National Institute of Medical Science and Nutrition
• • With more than 3 months with peritoneal dialysis treatment in the National Institute of Medical Science and Nutrition
• • With more than 3 months with hemodialysis treatment in the National Institute of Medical Science and Nutrition
• • Signed informed consent form
• Exclusion Criteria:
• * Patients with uncorrected cognitive problems:
• • Patients with post-dialytic syndrome (uremia).
• • Patients with neurological alterations induced by renal failure.
• * Patients with mental or psychiatric illness that prevents them from learning and following directions:
• • Patients with persistent delirium
• • Patients with schizophrenia
• • Patients with manic episode
• • Patients with confusional syndrome
• • Patients with minor or major neurocognitive deficits
• • Patients with dissociative amnesia
• • Patients with neurodevelopmental disorder
• • Patients who meet Diagnostic and Statistical Manual of Mental Disorders (DSM IV- TR) diagnostic criteria for substance abuse and dependence.